BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/24/2022 10:56:44 AM | Browse: 522 | Download: 1080
 |
Received |
|
2022-04-25 01:39 |
|
Peer-Review Started |
|
2022-04-25 01:42 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-05-31 02:14 |
|
Revised |
|
2022-06-12 21:10 |
|
Second Decision |
|
2022-08-09 02:55 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-08-11 04:39 |
|
Articles in Press |
|
2022-08-11 04:39 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-08-24 02:32 |
|
Publish the Manuscript Online |
|
2022-09-24 10:56 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Virology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Anjani Muthyala, Sandeep Sasidharan, Kevin John John, Amos Lal and Ajay K Mishra |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ajay K Mishra, FACP, MBBS, MD, Academic Fellow, Assistant Professor, Department of Cardiology, Saint Vincent Hospital, 123 Summer Street, Worcester, MA 01608, United States. ajay.mishra@stvincenthospital.com |
| Key Words |
SARS-CoV-2; Troponin; Brain natriuretic peptide; Prognosis; Outcomes; Heart failure |
| Core Tip |
Cardiac bioenzymes act as surrogate markers for various cardiovascular complications associated with coronavirus disease 2019 (COVID-19). Cardiac bioenzymes at admission and their serial monitoring can help assess the disease severity and predict mortality in patients with COVID-19. This review summarizes the role of these bioenzymes in diagnosis, prognosis and clinical implications on outcomes of various cardiovascular complications associated with COVID-19. |
| Publish Date |
2022-09-24 10:56 |
| Citation |
Muthyala A, Sasidharan S, John KJ, Lal A, Mishra AK. Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2. World J Virol 2022; 11(5): 375-390 |
| URL |
https://www.wjgnet.com/2220-3249/full/v11/i5/375.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v11.i5.375 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
